bpc 157 peptide safety BPC-157 vs. TB-500: What Patients Should Know What is BPC-157? | Everything

Metaxas C, Mathis D, Jeger C et al (2017) Early biomarker response and patient preferences to oral and intramuscular Vitamin B12 substitution in primary care: a randomized parallel-group trial

[DOI] [PMC free article] [PubMed] [Google Scholar] 30.Association between metformin and vitamin B12 deficiency in patients with type 2 diabetes: a systematic review and meta-analysis

B12 Injections, once learned and practiced, are easy to administer and require few supplies

This does not mean it would be ineffective for every patient but it does raise questions about expectations

A Phase I safety study and a Phase II ulcerative colitis trial of the BPC-157 formulation PL 14736 were conducted by the Croatian pharmaceutical company Pliva, but full peer-reviewed Phase II efficacy results have not been published